Potential Synergy Between ASIs and Anti-Angiogenic Agents Increases Survival in Patients With Glioma and Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effect of Angiotensin System Inhibitors on Survival in Newly Diagnosed Glioma Patients and Recurrent Glioblastoma Patients Receiving Chemotherapy and/or Bevacizumab
J. Neurooncol 2017 Jun 19;[EPub Ahead of Print], VA Levin, J Chan, M Datta, JL Yee, RK JainFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.